Structural Heart Devices Market Research Report – Forecast to 2023

Structural Heart Devices Market Research Report – Forecast to 2023

ID: MRFR/HC/4924-HCRR | November, 2018 | Region: Global | 100 pages | Half-Cooked Research Reports

Global Structural Heart Devices Market: Type (Heart Valve Devices, Annuloplasty Rings, Occluders, and Delivery Systems), Indication (Valvular Heart Disease, Cardiomyopathy), Procedure (Replacement Procedures, Repair Procedures)–Global Forecast Till 2023


Market Scenario


Global structural heart devices market is expected to grow at CAGR of 10.4% during the forecast period


Structural heart disease known as a non-coronary anomaly of the heart, therefore not disturbing the blood vessels in the heart. The structural heart diseases refer to cardiac defects which are inherited by birth and can be developed later in life. Common structural heart condition includes atrial septal defect, ventricular septal defect, paravalvular leak, arterial/venous fistulae, patent foramen oval and congenital heart disease.


The rise in the frequency of structural heart diseases and a rise in demand for minimally invasive techniques are factors that drive the growth of the market.  However, the high cost of surgeries and stringent government regulations hamper this growth. Equally, rise in emphasis of key players on research and development activities of structural heart devices and increase in demand for rapid and long-lasting procedures among the elderly population are likely to provide profitable breaks for the players in the structural heart devices market.


Advanced products such as sutureless heart valve cost pointedly higher than earlier available products. This double prices of the sutureless device will limit the adoption of the equipment’s, which in turn will restrain the growth of the market.


Segmentation


The global structural heart devices market has been segmented on the basis of type, indication, procedure, and end-user.


On the basis of type, the market has been classified as heart valve devices, occluders and delivery systems, annuloplasty rings, accessories, and other devices. The heart valve devices are segmented into transcatheter heart valves and surgical heart valves. The surgical heart valves are further sub-segmented into tissue heart valves and mechanical heart valves.


On the basis of indication, the market has been classified as valvular heart disease, cardiomyopathy, congenital heart defects, and others. The valvular heart disease is segmented into regurgitation and stenosis.


On the basis of procedure, the market has been classified as Replacement Procedures and repair procedures. The Replacement Procedures is segmented into TAVR procedures and SAVR procedures. The repair procedures are segmented into closure procedures, annuloplasty, valvuloplasty, and TMVR procedures.


On the basis of end-users, the market has been classified as hospitals, ambulatory surgery centers, and others.


On the basis of region, the market is segmented into the Americas, Europe, Asia-Pacific, and the Middle East and Africa. The Americas has been further segmented into North America and South America, with the North American market divided into the US and Canada.


The European structural heart devices market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. 


The structural heart devices market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The structural heart devices market in the Middle East and Africa has been segmented into the Middle East and Africa.


Regional Market Summary


Global Structural Heart Devices Market Share, by Region, 2017 (%)


Structural Heart Devices Market Share


Source: MRFR Analysis


In the structural heart devices market, North America is anticipated to account for the largest market share due to the early adoption of advanced medical technologies, the rise in awareness, the rise in growth of the healthcare sector, and due to favorable compensation setting for many surgical procedures.


 The European market is expected to hold the second largest market share. The market growth in this region can be attributed to rising frequency of cardiovascular disorders, increasing number of surgeries and increasing demand for advanced treatment procedures are boosting the European market.


The market share in Asia-Pacific is also projected to experience growth in the near future due to access to optimal treatment facilities and growing demand for advanced technology, better adoption rate, increase in disposable income, and rising medical tourism.


The market in the Middle East and Africa is expected to account for the smallest share of the global structural heart devices market due to an underdeveloped healthcare sector, lack of technical knowledge, and poor medical facilities.


Key Players


Some of the key players in the Edwards Lifesciences Corporation (US), Medtronic plc (Ireland), Abbott (US), Boston Scientific Corporation (US), and LivaNova plc (UK), ST. Jude Medical, Biomerics, Comed BV, JenaValve Technology, Inc., CardioKinetix, Cook Group Incorporated (US), Endologix Inc. (US)., and W. L. Gore & Associates, Inc. (US).


Global Structural Heart Devices Market, by Type



  • Heart Valve Devices

  • Transcatheter Heart Valves

  • Surgical Heart Valves

  • Tissue Heart Valves

  • Mechanical Heart Valves

  • Occluders and Delivery Systems

  • Annuloplasty Rings

  • Accessories

  • Other Devices


Global Structural Heart Devices Market, by Indication



  • Valvular Heart Disease

  • Regurgitation

  • Stenosis

  • Cardiomyopathy

  • Congenital Heart Defects

  • Others


Global Structural Heart Devices Market, by Procedure



  • Replacement Procedures

  • TAVR Procedures

  • SAVR Procedures

  • Repair Procedures

  • Closure Procedures

  • Annuloplasty

  • Valvuloplasty

  • TMVR Procedures


Global Structural Heart Devices Market, by End User



  • Hospitals

  • Ambulatory Surgical Centers

  • Others


Global Structural Heart Devices Market, by Region


Americas


  • North America

  • US

  • Canada

  • South America


Europe


  • Western Europe

  • Germany

  • France

  • Italy

  • Spain

  • UK

  • Rest of Western Europe

  • Eastern Europe


Asia-Pacific


  • Japan

  • China

  • India

  • Australia

  • South Korea

  • Rest of Asia-Pacific


Middle East & Africa


  • Middle East

  • Africa


Intended Audience



  • Hospitals

  • Healthcare corporations

  • Cardiac surgery centers

  • Structural heart device distributors

  • Medical service providers

  • Manufacturers of structural heart devices

  • Structural heart surgeons

Table of Contents:

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

Chapter 6. Global Structural Heart Devices Market, by Type

6.1 Introduction

6.2 Heart Valve Devices

6.2.1 Transcatheter Heart Valves

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

6.2.2 Surgical Heart Valves

6.2.2.1 Tissue Heart Valves

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

6.2.2.2 Mechanical Heart Valves

Market Estimates & Forecast, by Region, 2018

Market Estimates & Forecast, by Country, 2018–2023

6.3 Occluders and Delivery Systems

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

6.4 Annuloplasty Rings

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

6.5 Accessories

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

6.6 Other Devices

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023



Chapter 7. Global Structural Heart Devices Market, by Indication

7.1 Introduction

7.2 Valvular Heart Disease

7.2.1 Regurgitation

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

7.2.1 Stenosis

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

7.3 Cardiomyopathy

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

7.4 Congenital Heart Defects

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

7.5 Others

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023



Chapter 8. Global Structural Heart Devices Market, by Procedure

8.1 Introduction

8.2 Replacement Procedures

8.2.1 TAVR Procedures

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

8.2.2 SAVR Procedures

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

8.3 Repair Procedures

8.3.1 Closure Procedures

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

8.3.2 Annuloplasty

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

8.3.3 Valvuloplasty

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

8.3.4 TMVR Procedures

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023



Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

Chapter 9. Global Structural Heart Devices Market, by End-Users

9.1 Introduction

9.2 Hospitals

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

9.3 Ambulatory Surgery Centers

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

9.4 Others

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

Chapter 10. Global Structural Heart Devices, by Region

10.1 Introduction

10.2 Americas

10.2.1 North America

10.2.1.1 US

10.2.1.2 Canada

10.2.2 South America

10.3 Europe

10.3.1 Western Europe

10.3.1.1 Germany

10.3.1.2 France

10.3.1.3 Italy

10.3.1.4 Spain

10.3.1.5 UK

10.3.1.6 Rest of Western Europe

10.3.2 Eastern Europe

10.4 Asia-Pacific

10.4.1 Japan

10.4.2 China

10.4.3 India

10.4.4 Australia

10.4.5 South Korea

10.4.6 Rest of Asia-Pacific

10.5 Middle East & Africa

10.5.1 Middle East

10.5.2 Africa

Chapter 11. Company Landscape

11.1 Introduction

11.2 Market Share Analysis

11.3 Key Development & Strategies

Chapter 12. Company Profiles

12.1 Edwards Lifesciences Corporation

12.1.1 Company Overview

12.1.2 Type Overview

12.1.3 Financials Overview

12.1.4 Key Developments

12.1.5 SWOT Analysis

12.2 Medtronic plc

12.2.1 Company Overview

12.2.2 Type Overview

12.2.3 Financial Overview

12.2.4 Key Developments

12.2.5 SWOT Analysis

12.3 Abbott

12.3.1 Company Overview

12.3.2 Type Overview

12.3.3 Financial Overview

12.3.4 Key Development

12.3.5 SWOT Analysis

12.4 Boston Scientific Corporation

12.4.1 Company Overview

12.4.2 Technology/Business Segment Overview

12.4.3 Financial Overview

12.4.4 Key Development

12.4.5 SWOT Analysis

12.5 LivaNova plc

12.5.1 Company Overview

12.5.2 Type Overview

12.5.3 Financial overview

12.5.4 Key Developments

12.5.5 SWOT Analysis

12.6 ST. Jude Medical

12.6.1 Company Overview

12.6.2 Type Overview

12.6.3 Financial Overview

12.6.4 Key Developments

12.6.5 SWOT Analysis

12.7 Biomerics

12.7.1 Overview

12.7.2 Type Overview

12.7.3 Financial Overview

12.7.4 Key Developments

12.7.5 SWOT Analysis

12.8 Comed BV

12.8.1 Overview

12.8.2 Type/ Technology Overview

12.8.3 Financials

12.8.4 Key Developments

12.8.5 SWOT Analysis

12.9 JenaValve Technology, Inc.

12.9.1 Overview

12.9.2 Type Overview

12.9.3 Financials

12.9.4 Key Developments

12.9.5 SWOT Analysis

12.10 CardioKinetix

12.10.1 Overview

12.10.2 Type Overview

12.10.3 Financials

12.10.4 Key Developments

12.10.5 SWOT Analysis

12.12 Cook Group Incorporated

12.12.1 Overview

12.12.2 Type Overview

12.12.3 Financials

12.12.4 Key Developments

12.12.5 SWOT Analysis

12.12 Endologix Inc.

12.12.1 Overview

12.12.2 Type Overview

12.12.3 Financials

12.12.4 Key Developments

12.12.5 SWOT Analysis

12.13 W. L. Gore & Associates, Inc.

12.13.1 Overview

12.13.2 Type Overview

12.13.3 Financials

12.13.4 Key Developments

12.13.5 SWOT Analysis

Chapter 13 MRFR Conclusion

13.1 Key Findings

13.1.1 From CEO’s Viewpoint

13.1.2 Unmet Needs of the Market

13.2 Key Companies to Watch

13.3 Predictions for the Biosurgery Industry

Chapter 14. Appendix

LIST OF TABLES

Table 1 Global Structural Heart Devices Synopsis, 2018–2023

Table 2 Global Structural Heart Devices Estimates and Forecast, 2018–2023 (USD Million)

Table 3 Global Structural Heart Devices, by Region, 2018–2023 (USD Million)

Table 4 Global Structural Heart Devices, by Type, 2018–2023 (USD Million)

Table 5 Global Structural Heart Devices, by Indication, 2018–2023 (USD Million)

Table 6 Global Structural Heart Devices, by Procedure, 2018–2023 (USD Million)

Table 7 Global Structural Heart Devices, by End-users, 2018–2023 (USD Million)

Table 8 North America: Structural Heart Devices, by Type, 2018–2023 (USD

Million)

Table 9 North America: Structural Heart Devices, by Indication, 2018–2023 (USD

Million)

Table 10 North America: Structural Heart Devices, by Procedure, 2018–2023 (USD

Million)

Table 11 North America: Structural Heart Devices, by End-users, 2018–2023 (USD Million)

Table 12 US: Structural Heart Devices, by Type, 2018–2023 (USD Million)

Table 13 US: Structural Heart Devices, by Indication, 2018–2023 (USD Million)

Table 14 US: Structural Heart Devices, by Procedure, 2018–2023 (USD Million)

Table 15 US: Structural Heart Devices, by End-users, 2018–2023 (USD Million)

Table 16 Canada: Structural Heart Devices, by Type, 2018–2023 (USD Million)

Table 17 Canada: Structural Heart Devices, by Indication, 2018–2023 (USD Million)

Table 18 Canada: Structural Heart Devices, by Procedure, 2018–2023 (USD

Million)

Table 19 Canada Structural Heart Devices, by End-users, 2018–2023 (USD Million)

Table 20 South America: Structural Heart Devices, by Type, 2018–2023 (USD

Million)

Table 21 South America: Structural Heart Devices, by Indication, 2018–2023 (USD

Million)

Table 22 South America: Structural Heart Devices, by Procedure, 2018–2023 (USD

Million)

Table 23 South America: Structural Heart Devices, by End-users, 2018–2023 (USD Million)

Table 24 Europe: Structural Heart Devices, by Type, 2018–2023 (USD Million)

Table 25 Europe: Structural Heart Devices, by Indication, 2018–2023 (USD Million)

Table 26 Europe: Structural Heart Devices, by Procedure, 2018–2023 (USD Million)

Table 27 Europe: Structural Heart Devices, by End-users, 2018–2023 (USD Million)

Table 28 Western Europe: Structural Heart Devices, by Type, 2018–2023 (USD

Million)

Table 29 Western Europe: Structural Heart Devices, by Indication, 2018–2023 (USD

Million)

Table 30 Western Europe: Structural Heart Devices, by Procedure, 2018–2023

(USD Million)

Table 31 Western Europe: Structural Heart Devices, by End-users, 2018–2023 (USD Million)

Table 32 Eastern Europe: Structural Heart Devices, by Type, 2018–2023 (USD

Million)

Table 33 Eastern Europe: Structural Heart Devices, by Indication, 2018–2023 (USD

Million)

Table 34 Eastern Europe: Structural Heart Devices, by Procedure, 2018–2023

(USD Million)

Table 35 Eastern Europe: Structural Heart Devices, by End-users, 2018–2023 (USD Million)

Table 36 Asia-Pacific: Structural Heart Devices, by Type, 2018–2023 (USD

Million)

Table 37 Asia-Pacific: Structural Heart Devices, by Indication, 2018–2023 (USD

Million)

Table 38 Asia-Pacific: Structural Heart Devices, by Procedure, 2018–2023 (USD

Million)

Table 39 Asia-Pacific: Structural Heart Devices, by End-users, 2018–2023 (USD Million)

Table 40 Middle East & Africa: Structural Heart Devices, by Type, 2018–2023

(USD Million)

Table 41 Middle East & Africa: Structural Heart Devices, by Indication, 2018–2023

(USD Million)

Table 42 Middle East & Africa: Structural Heart Devices, by Procedure, 2018–2023

(USD Million)

Table 43 Middle East & Africa Structural Heart Devices, by End-users, 2018–2023 (USD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for Global Structural Heart Devices

Figure 3 Segmentation Market Dynamics for Global Structural Heart Devices

Figure 4 Global Structural Heart Devices Share, by Type, 2017

Figure 5 Global Structural Heart Devices Share, by Indication, 2017

Figure 6 Global Structural Heart Devices Share, by Procedure, 2017



Figure 7 Global Structural Heart Devices, by End-users, 2018–2023 (USD Million)

Figure 8 Global Structural Heart Devices Share, by Region, 2017

Figure 9 North America: Structural Heart Devices Share, by Country, 2017

Figure 10 Europe: Structural Heart Devices Share, by Country, 2017

Figure 11 Asia-Pacific: Structural Heart Devices Share, by Country, 2017

Figure 12 Middle East & Africa: Structural Heart Devices Share, by Country, 2017

Figure 13 Global Structural Heart Devices: Company Share Analysis, 2017 (%)

Figure 14 Edwards Lifesciences Corporation: Key Financials

Figure 15 Edwards Lifesciences Corporation Segmental Revenue

Figure 16 Edwards Lifesciences Corporation: Geographical Revenue

Figure 17 Medtronic plc.: Key Financials

Figure 18 Medtronic plc.: Segmental Revenue

Figure 19 Medtronic plc.: Geographical Revenue

Figure 20 Abbott: Key Financials

Figure 21 Abbott: Segmental Revenue

Figure 22 Abbott: Geographical Revenue

Figure 23 Boston Scientific Corporation: Key Financials

Figure 24 Boston Scientific Corporation: Segmental Revenue

Figure 25 Boston Scientific Corporation: Geographical Revenue

Figure 26 LivaNova plc.: Key Financials

Figure 27 LivaNova plc.: Segmental Revenue

Figure 28 LivaNova plc.: Geographical Revenue

Figure 29 ST. Jude Medical: Key Financials

Figure 30 ST. Jude Medical: Segmental Revenue

Figure 31 ST. Jude Medical: Geographical Revenue

Figure 32 Biomerics: Key Financials

Figure 33 Biomerics: Segmental Revenue

Figure 34 Biomerics: Geographical Revenue

Figure 35 Comed BV: Key Financials

Figure 36 Comed BV Segmental Revenue

Figure 37 Comed BV: Geographical Revenue

Figure 38 JenaValve Technology, Inc.: Key Financials

Figure 39 JenaValve Technology, Inc.: Segmental Revenue

Figure 40 JenaValve Technology, Inc.: Geographical Revenue

Figure 41 CardioKinetix: Key Financials

Figure 42 CardioKinetix: Segmental Revenue

Figure 43 CardioKinetix: Geographical Revenue

Figure 44 Cook Group Incorporated: Key Financials

Figure 45 Cook Group Incorporated: Segmental Revenue

Figure 46 Cook Group Incorporated: Geographical Revenue

Figure 47 Endologix Inc.: Key Financials

Figure 48 Endologix Inc.: Segmental Revenue

Figure 49 Endologix Inc.: Geographical Revenue

Figure 50 W.L. Gore & Associates: Key Financials

Figure 51 W.L. Gore & Associates: Segmental Revenue

Figure 52 W.L. Gore & Associates: Geographical Revenue